BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36343848)

  • 1. Emerging roles of PHLPP phosphatases in the nervous system.
    Mallick A; Sharma M; Dey CS
    Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.
    Sharma M; Dey CS
    Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.
    Jackson TC; Verrier JD; Semple-Rowland S; Kumar A; Foster TC
    J Neurochem; 2010 Nov; 115(4):941-55. PubMed ID: 20819118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
    Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
    J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
    Rajala RV; Kanan Y; Anderson RE
    Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
    Xiong X; Li X; Wen YA; Gao T
    J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
    Brognard J; Sierecki E; Gao T; Newton AC
    Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.
    Baffi TR; Cohen-Katsenelson K; Newton AC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLPP Signaling in Immune Cells.
    Lordén G; Lam AJ; Levings MK; Newton AC
    Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of survival signalling pathways by the phosphatase PHLPP.
    O'Neill AK; Niederst MJ; Newton AC
    FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase PHLPP controls the cellular levels of protein kinase C.
    Gao T; Brognard J; Newton AC
    J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHLPP Inhibitor NSC74429 Is Neuroprotective in Rodent Models of Cardiac Arrest and Traumatic Brain Injury.
    Jackson TC; Dezfulian C; Vagni VA; Stezoski J; Janesko-Feldman K; Kochanek PM
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.